ARTV
USDArtiva Biotherapeutics Inc. Common Stock
$3.550-0.010 (-0.281%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$3.560
High
$3.680
Low
$3.510
Volume
0.12M
Company Fundamentals
Market Cap
86.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.12M
Exchange
NGM
Currency
USD
52-Week Range
Low $1.47Current $3.550High $13.845
Related News
GlobeNewswire
Artiva Biotherapeutics to Host Virtual Event Discussing Initial Safety and Translational Data in up to 32 Patients with Autoimmune Disease Treated with AlloNK®
The virtual webcast will take place Wednesday, November 12, 2025, at 8 a.m. ET Initial safety data for 32 patients with autoimmune disease treated with AlloNK + monoclonal antibody (mAb) therapy, highlighting a
View more
GlobeNewswire
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in November
SAN DIEGO, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (NASDAQ:ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe, and accessible cell therapies for patients
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.